Why the study?
What are the initiation rates and long-term adherence to secondary preventive drugs after acute myocardial infarction, and how do they differ by PCI status?
What are the initiation rates and long-term adherence to secondary preventive drugs after acute myocardial infarction, and how do they differ by PCI status?
Non-PCI patients receive significantly fewer secondary preventive drugs after AMI compared to PCI patients, highlighting a critical gap in guideline-directed medical therapy.
Non-PCI AMI patients may face undertreatment gaps; this cohort finding leaves open whether targeted interventions improve outcomes.
Guideline-recommended secondary preventive drugs were prescribed to most patients discharged from hospital after AMI, but the percentage receiving such therapy was significantly lower in non-PCI patients. The long-time adherence was high, but few drug adjustments were performed during follow-up. More attention is needed to secondary preventive drug therapy in AMI patients not undergoing PCI.
No takes yet. Share an insight, caveat, or question.
Halvorsen et al. (2016) studied this question.